Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
272 | 3 | TOLL LIKE RECEPTORS//INFLAMMASOME//IMMUNOLOGY | 43791 |
703 | 2 | TOLL LIKE RECEPTORS//CPG ODN//INNATE IMMUNITY | 13334 |
8611 | 1 | ACTINIC KERATOSIS//IMIQUIMOD//INGENOL MEBUTATE | 1267 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ACTINIC KERATOSIS | authKW | 1438589 | 12% | 38% | 154 |
2 | IMIQUIMOD | authKW | 1379745 | 14% | 32% | 175 |
3 | INGENOL MEBUTATE | authKW | 694535 | 3% | 85% | 33 |
4 | IMIDAZOQUINOLINE | authKW | 329670 | 2% | 51% | 26 |
5 | IMMUNE RESPONSE MODIFIER | authKW | 308667 | 2% | 56% | 22 |
6 | ACTINIC KERATOSES | authKW | 273800 | 3% | 32% | 34 |
7 | KERATOSIS ACTINIC | authKW | 243317 | 1% | 65% | 15 |
8 | LOCAL SKIN RESPONSES | authKW | 149241 | 0% | 100% | 6 |
9 | DICLOFENAC 3 GEL | authKW | 124368 | 0% | 100% | 5 |
10 | PHARMACOCHEM BIOMOL | address | 124368 | 0% | 100% | 5 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Dermatology | 64955 | 54% | 0% | 683 |
2 | Immunology | 435 | 10% | 0% | 133 |
3 | Chemistry, Medicinal | 367 | 6% | 0% | 73 |
4 | Pharmacology & Pharmacy | 220 | 10% | 0% | 129 |
5 | Oncology | 213 | 9% | 0% | 112 |
6 | Surgery | 56 | 6% | 0% | 75 |
7 | Medicine, Research & Experimental | 24 | 3% | 0% | 37 |
8 | Primary Health Care | 11 | 0% | 0% | 5 |
9 | Infectious Diseases | 8 | 2% | 0% | 20 |
10 | Chemistry, Organic | 8 | 3% | 0% | 37 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHARMACOCHEM BIOMOL | 124368 | 0% | 100% | 5 |
2 | DERMATOL | 52648 | 37% | 0% | 464 |
3 | EXCELLENCE SCI AFFAIRS | 49747 | 0% | 100% | 2 |
4 | IFO IST DERMATOL | 49747 | 0% | 100% | 2 |
5 | M 3 | 49747 | 0% | 100% | 2 |
6 | SKIN CANC CHARITE | 46406 | 1% | 13% | 14 |
7 | BIOCHEM ENVIRONM | 37307 | 0% | 50% | 3 |
8 | DERMATOL OFF | 33163 | 0% | 67% | 2 |
9 | EA4215 | 33159 | 0% | 33% | 4 |
10 | 3M 275 2W 14 | 24874 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF DERMATOLOGY | 18366 | 7% | 1% | 91 |
2 | JOURNAL OF DRUGS IN DERMATOLOGY | 18287 | 3% | 2% | 36 |
3 | JOURNAL OF DERMATOLOGICAL TREATMENT | 12762 | 2% | 2% | 27 |
4 | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 10925 | 6% | 1% | 74 |
5 | DERMATOLOGIC SURGERY | 10765 | 3% | 1% | 43 |
6 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 10588 | 3% | 1% | 40 |
7 | CUTIS | 8468 | 3% | 1% | 38 |
8 | GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA | 6799 | 1% | 2% | 13 |
9 | JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 6524 | 1% | 2% | 15 |
10 | EUROPEAN JOURNAL OF DERMATOLOGY | 4058 | 2% | 1% | 21 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACTINIC KERATOSIS | 1438589 | 12% | 38% | 154 | Search ACTINIC+KERATOSIS | Search ACTINIC+KERATOSIS |
2 | IMIQUIMOD | 1379745 | 14% | 32% | 175 | Search IMIQUIMOD | Search IMIQUIMOD |
3 | INGENOL MEBUTATE | 694535 | 3% | 85% | 33 | Search INGENOL+MEBUTATE | Search INGENOL+MEBUTATE |
4 | IMIDAZOQUINOLINE | 329670 | 2% | 51% | 26 | Search IMIDAZOQUINOLINE | Search IMIDAZOQUINOLINE |
5 | IMMUNE RESPONSE MODIFIER | 308667 | 2% | 56% | 22 | Search IMMUNE+RESPONSE+MODIFIER | Search IMMUNE+RESPONSE+MODIFIER |
6 | ACTINIC KERATOSES | 273800 | 3% | 32% | 34 | Search ACTINIC+KERATOSES | Search ACTINIC+KERATOSES |
7 | KERATOSIS ACTINIC | 243317 | 1% | 65% | 15 | Search KERATOSIS+ACTINIC | Search KERATOSIS+ACTINIC |
8 | LOCAL SKIN RESPONSES | 149241 | 0% | 100% | 6 | Search LOCAL+SKIN+RESPONSES | Search LOCAL+SKIN+RESPONSES |
9 | DICLOFENAC 3 GEL | 124368 | 0% | 100% | 5 | Search DICLOFENAC+3+GEL | Search DICLOFENAC+3+GEL |
10 | RESIQUIMOD | 103769 | 1% | 38% | 11 | Search RESIQUIMOD | Search RESIQUIMOD |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |